Reconciling evidence-based and personalized medicine: perspectives in heart failure and cardiomyopathies
Listen to this summary
The authors explore how to reconcile evidence-based medicine (EBM) with personalized medicine (PM) in the management of heart failure and inherited cardiomyopathies, given the tension between population averages and individual patient needs. They examine the philosophical and practical implications of this interplay and propose a framework to harmonize both approaches, aiming to enhance patient outcomes in cardiovascular care. The review highlights the need for strategies that integrate the strengths of EBM and PM, particularly in the context of conditions with variable individual trajectories.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from European heart journal
View all →Sep 22, 2026 · European heart journal
Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation
Sep 21, 2026 · European heart journal
Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction
Sep 15, 2026 · European heart journal
Whole-grain consumption and cardiometabolic risk: a meta-analysis of randomized trials
Sep 10, 2026 · European heart journal
Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study
Sep 9, 2026 · European heart journal
Nighttime light exposure and cardiac structure and function
Sep 6, 2026 · European heart journal
Quality standards for preclinical research in cardio-oncology
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


